Showing results (81-90 of 183) with videos related to
Sort By:
Pageof 19
Journal of Clinical Pharmacology|June 25, 2020
The Effect of GS-548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS-6637 in Healthy AdultsHaden T Bunn, Elana Rosenthal, Poonam Mathur, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2010
HIV/Hepatitis C virus-coinfected virologic responders to pegylated interferon and ribavirin therapy more frequently incur interferon-related adverse events than nonresponders doAnu Osinusi, Joseph J Rasimas, Rachel Bishop, et al.Blood|April 20, 2004
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferationIrini Sereti, Kara B Anthony, Hector Martinez-Wilson, et al.Plos Pathogens|July 12, 2008
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individualsManuela Fogli, Domenico Mavilio, Enrico Brunetta, et al.The Journal of Infectious Diseases|March 23, 2021
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome CoronavirusesJoshua G Petrie, Latifa A Bazzi, Adrian B McDermott, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2024
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 VaccineDean Follmann, Allyson Mateja, Michael P Fay, et al.The Journal of Experimental Medicine|September 27, 2006
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionDomenico Mavilio, Gabriella Lombardo, Audrey Kinter, et al.The Journal of Infectious Diseases|February 18, 2011
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trialAnuradha Ganesan, Nancy Crum-Cianflone, Jeanette Higgins, et al.Plos One|March 27, 2012
Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV diseaseLotty Ledwaba, Jorge A Tavel, Paul Khabo, et al.Journal of the American College of Cardiology|September 6, 2003
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trialMichael Domanski, Heidi Krause-Steinrauf, Prakash Deedwania, et al.Pageof 19